Dysregulated cholesterol trafficking through ABCA1 drives neurodegeneration in Parkinson’s disease
This study identifies ABCA1 as a driver of dysregulated cholesterol trafficking in Parkinson’s disease, showing that reducing ABCA1 in astrocytes and neurons decreases cholesterol accumulation, α-synuclein pathology and neurodegeneration in mice.